Oral delivery of insulin / (Record no. 246954)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 06176cam a2200709Mi 4500 |
001 - CONTROL NUMBER | |
control field | ocn890162866 |
003 - CONTROL NUMBER IDENTIFIER | |
control field | OCoLC |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20190328114808.0 |
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS | |
fixed length control field | m o d |
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
fixed length control field | cr ||||||||||| |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 140915s2014 enk o 000 0 eng d |
010 ## - LIBRARY OF CONGRESS CONTROL NUMBER | |
LC control number | 2014950424 |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | UKMGB |
Language of cataloging | eng |
Description conventions | rda |
-- | pn |
Transcribing agency | UKMGB |
Modifying agency | N$T |
-- | OPELS |
-- | YDXCP |
-- | CHVBK |
-- | OCLCF |
-- | IDEBK |
-- | EBLCP |
-- | OCLCQ |
-- | CNCGM |
-- | MERER |
-- | OCLCQ |
-- | OCLCO |
-- | ITD |
-- | OCLCO |
-- | OCLCQ |
-- | U3W |
-- | D6H |
-- | OCLCQ |
-- | OTZ |
-- | WYU |
-- | LOA |
-- | CUY |
-- | ZCU |
-- | USU |
-- | MERUC |
-- | OCLCO |
-- | ICG |
-- | K6U |
-- | COCUF |
-- | OCLCQ |
-- | VT2 |
-- | DKC |
016 7# - NATIONAL BIBLIOGRAPHIC AGENCY CONTROL NUMBER | |
Record control number | 016869524 |
Source | Uk |
016 7# - NATIONAL BIBLIOGRAPHIC AGENCY CONTROL NUMBER | |
Record control number | 016856985 |
Source | Uk |
019 ## - | |
-- | 898422306 |
-- | 1066443727 |
-- | 1088966405 |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
International Standard Book Number | 9781908818683 |
Qualifying information | (electronic bk.) |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
International Standard Book Number | 1908818689 |
Qualifying information | (electronic bk.) |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
Canceled/invalid ISBN | 9781907568473 |
Qualifying information | (hbk.) |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
Canceled/invalid ISBN | 1907568476 (print) |
035 ## - SYSTEM CONTROL NUMBER | |
System control number | (OCoLC)890162866 |
Canceled/invalid control number | (OCoLC)898422306 |
-- | (OCoLC)1066443727 |
-- | (OCoLC)1088966405 |
050 #4 - LIBRARY OF CONGRESS CALL NUMBER | |
Classification number | RC661.I6 |
Item number | S66 2014 |
060 00 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER | |
Classification number | 2015 A-997 |
060 10 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER | |
Classification number | WK 820 |
072 #7 - SUBJECT CATEGORY CODE | |
Subject category code | HEA |
Subject category code subdivision | 039000 |
Source | bisacsh |
072 #7 - SUBJECT CATEGORY CODE | |
Subject category code | MED |
Subject category code subdivision | 014000 |
Source | bisacsh |
072 #7 - SUBJECT CATEGORY CODE | |
Subject category code | MED |
Subject category code subdivision | 022000 |
Source | bisacsh |
072 #7 - SUBJECT CATEGORY CODE | |
Subject category code | MED |
Subject category code subdivision | 112000 |
Source | bisacsh |
072 #7 - SUBJECT CATEGORY CODE | |
Subject category code | MED |
Subject category code subdivision | 045000 |
Source | bisacsh |
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER | |
Classification number | 616.462061 |
Edition number | 23 |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Sonia, Thundiparambil Azeez, |
Relator term | author. |
245 10 - TITLE STATEMENT | |
Title | Oral delivery of insulin / |
Medium | [electronic resource] |
Statement of responsibility, etc. | Thundiparambil Azeez Sonia, Chandra P. Sharma. |
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Place of production, publication, distribution, manufacture | Oxford : |
Name of producer, publisher, distributor, manufacturer | Woodhead Publishing, |
Date of production, publication, distribution, manufacture, or copyright notice | 2014. |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 1 online resource. |
336 ## - CONTENT TYPE | |
Content type term | text |
Content type code | txt |
Source | rdacontent |
337 ## - MEDIA TYPE | |
Media type term | computer |
Media type code | c |
Source | rdamedia |
338 ## - CARRIER TYPE | |
Carrier type term | online resource |
Carrier type code | cr |
Source | rdacarrier |
490 1# - SERIES STATEMENT | |
Series statement | Woodhead publishing series in biomedicine ; |
Volume/sequential designation | number 41 |
588 0# - SOURCE OF DESCRIPTION NOTE | |
Source of description note | CIP data; item not viewed. |
520 ## - SUMMARY, ETC. | |
Summary, etc. | Diabetes Mellitus, a syndrome of disordered metabolism, characterised by abnormal elevation in blood glucose level, has become a life-threatening condition for many people. Current means of therapy for Diabetes Mellitus do not mimic the normal physiological pattern of insulin release. Oral delivery is the preferred route of administration due to its non-invasive nature. Oral delivery of insulin presents an overview of Diabetes Mellitus, and discusses the strategies and techniques adopted for oral delivery of insulin. This title begins with an introductory chapter on symptoms, complications and therapy for Diabetes Mellitus. Subsequent chapters cover the various routes for administering insulin; the challenges and strategies of oral delivery; experimental techniques in the development of an oral insulin carrier; lipids; inorganic nanoparticles and polymers in oral insulin delivery; and a summary and presentation of future perspectives on oral delivery of insulin. |
505 00 - FORMATTED CONTENTS NOTE | |
Miscellaneous information | Machine generated contents note: |
-- | 1. |
Title | Diabetes mellitus -- an overview -- |
Miscellaneous information | 1.1. |
Title | Diabetes mellitus -- an introduction -- |
Miscellaneous information | 1.2. |
Title | Glucose homeostasis -- |
Miscellaneous information | 1.3. |
Title | Types of diabetes -- |
Miscellaneous information | 1.4. |
Title | Symptoms of diabetes -- |
Miscellaneous information | 1.5. |
Title | Complications of diabetes -- |
Miscellaneous information | 1.6. |
Title | Diagnosis of diabetes mellitus -- |
Miscellaneous information | 1.7. |
Title | Therapy for diabetes -- |
Miscellaneous information | 1.8. |
Title | Non-insulin treatment options of type 1 diabetes -- |
Miscellaneous information | 1.9. |
Title | Treatment options of type 2 diabetes -- |
Miscellaneous information | 1.10. |
Title | Conclusion -- |
Miscellaneous information | 1.11. |
Title | References -- |
Miscellaneous information | 2. |
Title | Routes of administration of insulin -- |
Miscellaneous information | 2.1. |
Title | Current approach for the delivery of insulin -- |
Miscellaneous information | 2.2. |
Title | Routes of administration of insulin -- |
Miscellaneous information | 2.3. |
Title | Conclusion -- |
Miscellaneous information | 2.4. |
Title | References -- |
Miscellaneous information | 3. |
Title | Oral insulin delivery -- challenges and strategies -- |
Miscellaneous information | 3.1. |
Title | Oral delivery of insulin -- |
Miscellaneous information | 3.2. |
Title | Barriers to oral delivery of insulin -- |
Miscellaneous information | 3.3. |
Title | Strategies and alternatives to improve oral insulin delivery -- |
Miscellaneous information | 3.4. |
Title | Conclusion -- |
Miscellaneous information | 3.5. |
Title | References -- |
Miscellaneous information | 4. |
Title | Experimental techniques involved in the development of oral Insulin carriers -- |
Miscellaneous information | 4.1. |
Title | Introduction -- |
Miscellaneous information | 4.2. |
Title | Polymeric nanoparticles -- |
Miscellaneous information | 4.3. |
Title | Physicochemical characterization of nanoparticles -- |
Miscellaneous information | 4.4. |
Title | Biological evaluation -- |
Miscellaneous information | 4.5. |
Title | In vitro method for assessing drug permeability -- |
Miscellaneous information | 4.6. |
Title | In vivo study of oral insulin -- |
Miscellaneous information | 4.7. |
Title | Biodistribution studies -- |
Miscellaneous information | 4.8. |
Title | Conclusion -- |
Miscellaneous information | 4.9. |
Title | References -- |
Miscellaneous information | 5. |
Title | Lipids and inorganic nanoparticles in oral insulin delivery -- |
Miscellaneous information | 5.1. |
Title | Lipid-based systems for oral delivery of insulin -- |
Miscellaneous information | 5.2. |
Title | Liposomes -- |
Miscellaneous information | 5.3. |
Title | Solid lipid nanoparticles -- |
Miscellaneous information | 5.4. |
Title | Nanostructured lipid carriers -- |
Miscellaneous information | 5.5. |
Title | Niosomes -- |
Miscellaneous information | 5.6. |
Title | Archaeosomes -- |
Miscellaneous information | 5.7. |
Title | Cubic nanoparticles (cubosomes) -- |
Miscellaneous information | 5.8. |
Title | Aquasomes -- |
Miscellaneous information | 5.9. |
Title | Inorganic nanoparticles as carriers for oral insulin delivery -- |
Miscellaneous information | 5.10. |
Title | Conclusion -- |
Miscellaneous information | 5.11. |
Title | References -- |
Miscellaneous information | 6. |
Title | Polymers in oral insulin delivery -- |
Miscellaneous information | 6.1. |
Title | Introduction -- |
Miscellaneous information | 6.2. |
Title | Characteristics of an ideal oral insulin carrier -- |
Miscellaneous information | 6.3. |
Title | Polymers in oral insulin delivery -- |
Miscellaneous information | 6.4. |
Title | Natural polymers -- |
Miscellaneous information | 6.5. |
Title | Synthetic polymers -- |
Miscellaneous information | 6.6. |
Title | Conclusion -- |
Miscellaneous information | 6.7. |
Title | References -- |
Miscellaneous information | 7. |
Title | Summary and future perspectives for oral insulin delivery -- |
Miscellaneous information | 7.1. |
Title | Introduction -- |
Miscellaneous information | 7.2. |
Title | Technologies developed for clinical applications of oral insulin delivery -- |
Miscellaneous information | 7.3. |
Title | Conclusions and future perspectives -- |
Miscellaneous information | 7.4. |
Title | References. |
504 ## - BIBLIOGRAPHY, ETC. NOTE | |
Bibliography, etc | Includes bibliographical references and index. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Insulin |
General subdivision | Therapeutic use |
-- | Administration. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Diabetes |
General subdivision | Oral therapy. |
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | HEALTH & FITNESS |
General subdivision | Diseases |
-- | General. |
Source of heading or term | bisacsh |
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | MEDICAL |
General subdivision | Clinical Medicine. |
Source of heading or term | bisacsh |
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | MEDICAL |
General subdivision | Diseases. |
Source of heading or term | bisacsh |
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | MEDICAL |
General subdivision | Evidence-Based Medicine. |
Source of heading or term | bisacsh |
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | MEDICAL |
General subdivision | Internal Medicine. |
Source of heading or term | bisacsh |
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Diabetes |
General subdivision | Oral therapy. |
Source of heading or term | fast |
Authority record control number | (OCoLC)fst00892178 |
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Insulin |
General subdivision | Therapeutic use |
-- | Administration. |
Source of heading or term | fast |
Authority record control number | (OCoLC)fst00974518 |
650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Insulin |
General subdivision | administration & dosage. |
Authority record control number | (DNLM)D007328Q000008 |
650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Administration, Oral. |
Authority record control number | (DNLM)D000284 |
650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Drug Delivery Systems. |
Authority record control number | (DNLM)D016503 |
655 #4 - INDEX TERM--GENRE/FORM | |
Genre/form data or focus term | Electronic books. |
655 #0 - INDEX TERM--GENRE/FORM | |
Genre/form data or focus term | Electronic book. |
655 #7 - INDEX TERM--GENRE/FORM | |
Genre/form data or focus term | Electronic books. |
Source of term | lcgft |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Sharma, Chandra P., |
Relator term | author. |
776 08 - ADDITIONAL PHYSICAL FORM ENTRY | |
Relationship information | Print version: |
Main entry heading | Sharma, C.P. |
Title | Oral delivery of insulin. |
Place, publisher, and date of publication | Cambridge : Woodhead, 2014 |
International Standard Book Number | 9781907568473 |
Record control number | (DLC) 2014950424 |
-- | (OCoLC)876802531 |
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE | |
Uniform title | Woodhead Publishing series in biomedicine ; |
Volume number/sequential designation | no. 41. |
International Standard Serial Number | 2050-0289 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Materials specified | ScienceDirect |
Uniform Resource Identifier | http://www.sciencedirect.com/science/book/9781907568473 |
No items available.